Synapticure Secures $25M to Revolutionize Neurodegenerative Care
Slice of Healthcare Team
Nov 22, 2024
Key Highlights
- $25M Series A funding led by B Capital, joined by CVS Health Ventures, CommonSpirit Health, and others.
- Innovative AI-driven platform enhances diagnosis, treatment, and caregiver support for neurodegenerative diseases.
- Focus on expanding partnerships, scaling operations, and increasing access to clinical trials across the U.S.
Source: Direct
Notable Quotes
“ This investment will enable Synapticure to continue to democratize care for people and their families living with neurodegenerative diseases. ”
Sandra Abrevaya, CEO at Synapticure
“ Synapticure’s mission aligns closely with our focus on investing in transformative healthcare companies led by visionary founders. ”
Adam Seabrook, Partner at B Capital
“ We believe we go farther, faster when we work with partners who champion new models of care. ”
Anuradhika A., System VP at CommonSpirit Health
-2e14ed90-63f5-4ce1-84fc-3fa9506b84be.png&w=3840&q=75)
